UK says monkeypox vaccine ‘78% effective’, Health News, ET HealthWorld

London: British public health officials said on Tuesday the monkeypox vaccine was 78% effective, urging men who have sex with men to take the vaccine.

The UK Health Safety Agency said its latest analysis “gives an estimate of vaccine efficacy for a single dose of 78% at 14 days or more after vaccination”.

He described the results as “the strongest British evidence to date” for the effectiveness of the jab.

The Bavarian Nordic of Denmark is the only laboratory manufacturing a licensed monkeypox vaccine, called MVA-BN.

He said last week he had signed an agreement to supply European countries with up to two million doses of the vaccine.

More than 55,000 doses of vaccines have been administered in England, said NHS National Director of Vaccinations and Screening Steve Russell.

“We now know how effective the vaccine is, providing 78% protection against the virus from a single dose.”

The latest outbreak of monkeypox began spreading around the world in May and peaked in July.

The UKHSA said its findings were based on analysis of 363 cases of monkeypox between July and November in England.

Most cases involved gay and bisexual men and other people who have sex with men. Of those who caught the virus, 323 had not been vaccinated.

“We now know that a single dose of vaccine provides strong protection against monkeypox, which shows how important vaccination is to protect yourself and others,” said Jamie Lopez-Bernal, consultant epidemiologist at the UKHSA.

“A second dose should provide even greater and longer lasting protection,” he added.

The UK has recorded 3,570 confirmed cases of monkeypox, which causes fever, muscle aches and large boil-like skin lesions.